What is HLN's P/E ratio?

Haleon PLC (HLN) currently trades at a P/E ratio of 15.79.

Haleon PLC reports a Return on Equity (ROE) of 9.94%.

What is HLN's dividend yield?

Haleon PLC offers a dividend yield of 1.96%.

What is HLN's Quality Score?

Our AI rates HLN's overall financial quality at 77 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy HLN?

Our AI Timing Score for HLN is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does HLN belong to?

Haleon PLC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange

Haleon PLC (HLN) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2025-12-31)

HLN AI Analysis Summary

Our AI summary for HLN: Haleon PLC (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 15.79, ROE of 9.94%, a dividend yield of 1.96%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

HLN

Haleon PLC

USD 9.80

-0.07 (-0.71%) Day Change

Watchlist Portfolio Compare Chart

15.79

P/E

0.52

D/E

9.9%

ROE

5.0%

ROA

1.96%

Div Yield

HALEON PLC
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 9.80 Price -0.07 (-0.71%) Day Change	NEWS SCORE: 99

HLN, the overall quality is good ( Quality = 77) and the timing to buy is ...(Sign In to See)...

Loading chart...

77 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: ROE is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	1369
Magic Formula Rank by ROE	1369
Magic Formula Rank by ROIC	1636
Price	9.80
PBV / Sector	2.67 / 9.54
Earning Per Share	0.36

PE / Sector	15.79 / 28.71
PEG or PE/Growth / Sector	N/A / -0.10
Average 1M Daily Value	107.49 M GREAT
Average 1W Daily Value	169.09 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

70%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	14.78 / 15.25
NPM Average (%) / Sector	11.67 / -10.83 GOOD
NPM Change Average (%) / Sector	16.18 / 117.82 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	5.01 / 8.18
ROA Average (%) / Sector	3.83 / 2.87
ROA Change Average (%) / Sector	18.90 / 113.04 GOOD
ROE (%) / Sector	9.94 / 26.68
ROE Average (%) / Sector	7.92 / 13.89
ROE Change Average (%) / Sector	16.67 / 379.20 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

41%

Dividend (%) / Sector	1.96 / 0.52
Dividend Average (%) / Sector	1.67 / 3.06
Dividend Change Average (%) / Sector	14.80 / 13.83 GOOD

Registration Details

Analyze Date	2026-08-04 08:01:38
Symbol	HLN
Name	HALEON PLC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NYSE
Listed Shares	4,403.80 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	43,914.32 / 10,605.93

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: The Heights, Weybridge, United Kingdom, KT13 0NY

Phone: 44 1932 959 500

Website: https://www.haleon.com

Employees: 24,535

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.